08:38:53 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



Diamedica Therapeutics Inc (2)
Symbol DMA
Shares Issued 7,856,875
Close 2018-12-14 C$ 4.70
Market Cap C$ 36,927,313
Recent Sedar Documents

Diamedica 4.1-million-share prospectus offering

2018-12-14 20:36 ET - Prospectus Approved

Effective Dec. 6, 2018, the company's (final) Form S-1 registration statement dated Dec. 6, 2018, qualifying the distribution of 4.1 million common shares of the company, was filed with and accepted by the TSX Venture Exchange and filed with the U.S. Securities and Exchange Commission (SEC).

The exchange has been advised that the closing of the offering occurred on Dec. 11, 2018, for aggregate gross proceeds of $16.4-million (U.S.).

Offering:  4.1 million common shares

Share price:  $4 (U.S.) per share

Underwriter:  Craig-Hallum Capital Group

Underwriter's commission:  aggregate cash commission of $1,066,000 (U.S.) and 205,000 broker warrants (Each broker warrant entitles the holder to acquire one common share at $4.80 (U.S.) for a five-year period.)

For further details, please refer to the company's news release Dec. 11, 2018.

© 2024 Canjex Publishing Ltd. All rights reserved.